Display options
Cite
Mion F, Vetrano S, Tonon S, et al. Reciprocal influence of B cells and tumor macro and microenvironments in the . Oncoimmunology. 2017;6(8):e1336593doi: 10.1080/2162402X.2017.1336593.
Mion, F., Vetrano, S., Tonon, S., Valeri, V., Piontini, A., Burocchi, A., Petti, L., Frossi, B., Gulino, A., Tripodo, C., Colombo, M. P., & Pucillo, C. E. (2017). Reciprocal influence of B cells and tumor macro and microenvironments in the . Oncoimmunology, 6(8), e1336593. https://doi.org/10.1080/2162402X.2017.1336593
Mion, Francesca, et al. "Reciprocal influence of B cells and tumor macro and microenvironments in the ." Oncoimmunology vol. 6,8 (2017): e1336593. doi: https://doi.org/10.1080/2162402X.2017.1336593
Mion F, Vetrano S, Tonon S, Valeri V, Piontini A, Burocchi A, Petti L, Frossi B, Gulino A, Tripodo C, Colombo MP, Pucillo CE. Reciprocal influence of B cells and tumor macro and microenvironments in the . Oncoimmunology. 2017 Jun 19;6(8):e1336593. doi: 10.1080/2162402X.2017.1336593. eCollection 2017. PMID: 28919998; PMCID: PMC5593718.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2017 Jun 19;6(8):e1336593. doi: 10.1080/2162402X.2017.1336593. eCollection 2017.

Reciprocal influence of B cells and tumor macro and microenvironments in the .

Oncoimmunology

Francesca Mion, Stefania Vetrano, Silvia Tonon, Viviana Valeri, Andrea Piontini, Alessia Burocchi, Luciana Petti, Barbara Frossi, Alessandro Gulino, Claudio Tripodo, Mario P Colombo, Carlo E Pucillo

Affiliations

  1. Department of Medicine, University of Udine, Udine, Italy.
  2. Inflammatory Bowel Disease Center, Humanitas Research Hospital, Rozzano, Italy.
  3. Department of Biomedical Sciences, Humanitas University, Milano, Italy.
  4. Department of Experimental Oncology and Molecular Medicine, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  5. Department of Biotechnology and Translational Medicine, University of Milan, Milano, Italy.
  6. Department of Health Science, Tumor Immunology Unit, Human Pathology Section, Palermo University School of Medicine, Palermo, Italy.

PMID: 28919998 PMCID: PMC5593718 DOI: 10.1080/2162402X.2017.1336593

Abstract

One of the most fascinating aspects of the immune system is its dynamism, meant as the ability to change and readapt according to the organism needs. Following an insult, we assist to the spontaneous organization of different immune cells which cooperate, locally and at distance, to build up an appropriate response. Throughout tumor progression, adaptations within the systemic tumor environment, or macroenvironment, result in the promotion of tumor growth, tumor invasion and metastasis to distal organs, but also to dramatic changes in the activity and composition of the immune system. In this work, we show the changes of the B-cell arm of the immune system following tumor progression in the

Keywords: ApcMin/+ mice; B lymphocytes; IL-10; IgA; intestinal cancer

References

  1. Adv Cancer Res. 2015;128:235-62 - PubMed
  2. Br J Surg. 2002 Jul;89(7):845-60 - PubMed
  3. Cancer Immunol Immunother. 2011 May;60(5):609-19 - PubMed
  4. Cancer Res. 2007 Jan 1;67(1):425; author reply 426 - PubMed
  5. J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6 - PubMed
  6. J Indian Med Assoc. 2002 Aug;100(8):495-6 - PubMed
  7. Sci Rep. 2015 Jul 20;5:12255 - PubMed
  8. Blood. 2004 Feb 1;103(3):1050-8 - PubMed
  9. Am J Pathol. 2014 Nov;184(11):3120-9 - PubMed
  10. Int J Cancer. 2016 Sep 1;139(5):1129-39 - PubMed
  11. Semin Oncol. 2014 Apr;41(2):281-95 - PubMed
  12. J Pathol. 2016 Jan;238(2):141-51 - PubMed
  13. J Immunol. 1998 Aug 15;161(4):1710-7 - PubMed
  14. PLoS One. 2011;6(12):e28858 - PubMed
  15. Nat Rev Cancer. 2013 Oct;13(10 ):739-52 - PubMed
  16. Int J Exp Pathol. 2006 Jun;87(3):227-36 - PubMed
  17. Int J Dev Biol. 2011;55(7-9):889-97 - PubMed
  18. J Immunol. 2006 Jan 15;176(2):790-802 - PubMed
  19. Nat Commun. 2016 Jul 06;7:12150 - PubMed
  20. Gut Microbes. 2014;5(5):652-62 - PubMed
  21. Cell Mol Immunol. 2017 Jul;14 (7):597-606 - PubMed
  22. Mol Immunol. 2014 Dec;62(2):266-76 - PubMed
  23. Cancer Immunol Immunother. 2013 Jan;62(1):87-99 - PubMed
  24. Int J Cancer. 2016 Sep 15;139(6):1358-71 - PubMed
  25. J Immunol Res. 2014;2014:686879 - PubMed
  26. Annu Rev Immunol. 2012;30:221-41 - PubMed
  27. J Immunol. 2012 Sep 1;189(5):2300-8 - PubMed
  28. Int Immunol. 2015 Oct;27(10):531-6 - PubMed
  29. J Immunol. 2008 Apr 1;180(7):4763-73 - PubMed
  30. Ann N Y Acad Sci. 2010 Jan;1183:38-57 - PubMed
  31. PLoS One. 2009 Jul 29;4(7):e6412 - PubMed
  32. DNA Cell Biol. 2014 Dec;33(12):823-9 - PubMed
  33. Science. 2004 Jun 18;304(5678):1808-10 - PubMed
  34. Oncotarget. 2014 Jul 15;5(13):4651-64 - PubMed
  35. J Leukoc Biol. 2015 Mar;97(3):573-82 - PubMed
  36. J Immunol. 1998 Nov 15;161(10):5217-25 - PubMed
  37. J Immunol. 2007 Oct 15;179(8):5326-34 - PubMed
  38. J Immunol. 2012 Sep 1;189(5):2226-33 - PubMed
  39. Nat Rev Immunol. 2008 Jun;8(6):421-34 - PubMed
  40. Int Immunol. 2015 Oct;27(10):521-30 - PubMed
  41. Immunol Rev. 2008 Aug;224:201-14 - PubMed
  42. Cancer Res. 2006 Jul 15;66(14):7370-7 - PubMed
  43. J Immunol. 2003 Apr 1;170(7):3799-805 - PubMed
  44. Cancer Immunol Immunother. 2013 Jun;62(6):989-97 - PubMed
  45. Int J Cancer. 2005 Nov 20;117(4):574-86 - PubMed
  46. Int Immunol. 2015 Oct;27(10):479-86 - PubMed
  47. Int J Mol Sci. 2016 Jun 29;17 (7): - PubMed
  48. J Immunol. 2009 Jun 15;182(12):7459-72 - PubMed
  49. Cancer Sci. 2007 Jan;98(1):6-10 - PubMed
  50. Mol Cancer. 2014 May 04;13:99 - PubMed
  51. Cancer. 1987 May 15;59(10):1727-31 - PubMed
  52. Pathol Res Pract. 1980 Dec;170(1-3):126-45 - PubMed
  53. J Cell Mol Med. 2013 Sep;17(9):1088-95 - PubMed
  54. Nat Rev Rheumatol. 2010 Nov;6(11):636-43 - PubMed
  55. J Gastrointest Oncol. 2015 Apr;6(2):208-23 - PubMed
  56. Blood. 2003 Dec 1;102(12):4076-83 - PubMed

Publication Types